0001037868FALSE00010378682025-10-302025-10-30

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
__________________
FORM 8-K
__________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 30, 2025
__________________
AMETEK, Inc.
(Exact name of registrant as specified in its charter)
__________________
Delaware1-1298114-1682544
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
1100 Cassatt Road
Berwyn,
Pennsylvania
19312
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (610) 647-2121
Not Applicable
(Former name or former address, if changed since last report)
__________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchange on which registered
Common Stock, $0.01 Par Value (voting)AMENew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 



Item 2.02 Results of Operations and Financial Condition.
On October 30, 2025, AMETEK, Inc. (the “Company”) issued a press release announcing its financial results for the three and nine months ended September 30, 2025. A copy of the release is furnished as Exhibit 99.1 and incorporated by reference herein. This Current Report on Form 8-K and the press release attached hereto are being furnished pursuant to Item 2.02 of Form 8-K.
The information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Description
 
104Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AMETEK, Inc.
October 30, 2025By:/s/ THOMAS M. MONTGOMERY
Name: Thomas M. Montgomery
Title: Senior Vice President – Comptroller


Exhibit 99.1
a65.jpg
AMETEK Announces Record Third Quarter Results and
Raises Full Year Guidance

Berwyn, Pa., October 30, 2025 – AMETEK, Inc. (NYSE: AME) today announced record financial results for the third quarter ended September 30, 2025.

AMETEK’s third quarter 2025 sales were a record $1.89 billion, an 11% increase over the third quarter of 2024. On a GAAP basis, third quarter earnings per diluted share were $1.60. Adjusted earnings in the quarter were a record $1.89 per diluted share, up 14% from the third quarter of 2024. Adjusted earnings adds back non-cash, after-tax, acquisition-related intangible amortization of $0.22 per diluted share and excludes acquisition-related pre-tax costs of $19.7 million, or $0.07 per diluted share, for the FARO Technologies acquisition.

GAAP operating income was a record $488.4 million, or 25.8% of sales. Adjusted operating income was a record $496.1 million, up 11% versus last year’s third quarter. A reconciliation of reported GAAP results to adjusted results is included in the financial tables accompanying this release and on the AMETEK website.

"AMETEK delivered impressive results in the third quarter, highlighted by double digit growth in sales, orders and earnings per share, along with an outstanding 90 basis points of margin expansion excluding the impact of recent acquisitions," stated David A. Zapico, AMETEK Chairman and Chief Executive Officer. "The strength of the AMETEK Growth Model and the excellent contributions from our colleagues led to record results in the quarter."

Electronic Instruments Group (EIG)
EIG sales in the third quarter were a record $1.25 billion, an increase of 10% over the same period in 2024. On a GAAP basis, EIG’s third quarter operating income was $352.4 million, or 28.3% of sales. Adjusted EIG operating income was $360.2 million, up 6% from the prior year.

"EIG delivered solid results in the quarter with strong profit growth and 50 basis points of margin expansion excluding the impact of recent acquisitions," stated Mr. Zapico. “Additionally, we are pleased with the progress of the Faro Technologies integration and excited for the growth opportunities ahead for our expanded metrology platform.”


Page | 1
image_3.jpg


Electromechanical Group (EMG)
EMG sales in the third quarter were a record $646.3 million, up 13% from the third quarter of 2024. EMG’s third quarter operating income increased 25% to a record $163.9 million, and operating income margins were 25.4% in the quarter, up 250 basis points versus the prior year’s results.

“EMG's third quarter results were outstanding, with broad based sales and orders growth led by Paragon Medical, resulting in record operating income and sizeable margin expansion," noted Mr. Zapico. "This performance reflects the strength of our differentiated businesses and our unwavering focus on operational excellence."

2025 Outlook
“Our businesses performed exceptionally well in the third quarter, delivering strong growth and impressive operating results,” noted Mr. Zapico. “AMETEK’s flexible operating structure, diverse and attractive end market exposures, and strong cash flows position us well for sustained success.”

“For 2025, we continue to expect overall sales to be up mid-single digits compared to 2024. Adjusted earnings per diluted share are now expected to be in the range of $7.32 to $7.37, up 7% to 8% over the comparable basis for 2024. This is an increase from our previous guidance range of $7.06 to $7.20,” he added.

“For the fourth quarter of 2025, overall sales are expected to be up approximately 10% compared to the same period last year. Adjusted earnings in the quarter are anticipated to be in the range of $1.90 to $1.95 per share, up 2% to 4% compared to the fourth quarter of 2024," concluded Mr. Zapico.

Conference Call
AMETEK will webcast its third quarter 2025 investor conference call on Thursday, October 30, 2025, beginning at 8:30 AM ET. The live audio webcast will be available and later archived in the Investors section of www.ametek.com.

About AMETEK
AMETEK (NYSE: AME) is a leading global provider of industrial technology solutions serving a diverse set of attractive niche markets with annualized sales of approximately $7.5 billion. The AMETEK Growth Model integrates the Four Growth Strategies - Operational Excellence, Technology Innovation, Global and Market Expansion, and Strategic Acquisitions - with a disciplined focus on cash generation and capital deployment. AMETEK's objective is double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital. Founded in 1930, AMETEK has been listed on the NYSE for 95 years and is a component of the S&P 500. For more information, visit www.ametek.com.

Page | 2
image_3.jpg


Forward-looking Information
Statements in this news release relating to future events, such as AMETEK’s expected business and financial performance, are "forward-looking statements." Forward-looking statements are subject to various factors and uncertainties that may cause actual results to differ materially from expectations. These factors and uncertainties include risks related to AMETEK’s ability to consummate and successfully integrate future acquisitions; risks with international sales and operations, including supply chain disruptions, tariffs, trade disputes and currency conditions; AMETEK’s ability to successfully develop new products, open new facilities or transfer product lines; the price and availability of raw materials; compliance with government regulations, including environmental regulations; changes in the competitive environment or the effects of competition in our markets; the ability to maintain adequate liquidity and financing sources; and general economic conditions affecting the industries we serve. A detailed discussion of these and other factors that may affect our future results is contained in AMETEK’s filings with the U.S. Securities and Exchange Commission, including its most recent reports on Forms 10-K, 10-Q and 8-K. AMETEK disclaims any intention or obligation to update or revise any forward-looking statements.

Contact:
Kevin Coleman
Vice President, Investor Relations and Treasurer
kevin.coleman@ametek.com
Phone: 610.889.5247
Page | 3
image_3.jpg


AMETEK, Inc.
Consolidated Statement of Income
(In thousands, except per share amounts)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025202420252024
Net sales$1,892,641 $1,708,564 $5,402,668 $5,179,578 
Cost of sales1,206,505 1,092,754 3,455,643 3,347,860 
Selling, general and administrative197,756 169,959 542,190 521,137 
     Total operating expenses 1,404,261 1,262,713 3,997,833 3,868,997 
Operating income 488,380 445,851 1,404,835 1,310,581 
Interest expense(22,514)(25,118)(58,364)(90,962)
Other (expense) income, net(17,901)(1,888)(22,115)(2,435)
Income before income taxes447,965 418,845 1,324,356 1,217,184 
Provision for income taxes76,549 78,604 242,815 228,317 
Net income$371,416 $340,241 $1,081,541 $988,867 
Diluted earnings per share$1.60 $1.47 $4.67 $4.26 
Basic earnings per share$1.61 $1.47 $4.69 $4.28 
Weighted average common shares outstanding:
     Diluted shares231,670232,224231,561232,188
     Basic shares230,733231,342230,740231,292
Dividends per share$0.31 $0.28 $0.93 $0.84 

AMETEK, Inc.
Information by Business Segment
(In thousands)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025202420252024
Net sales:
Electronic Instruments$1,246,332 $1,134,588 $3,549,576 $3,444,980 
Electromechanical646,309 573,976 1,853,092 1,734,598 
Consolidated net sales$1,892,641 $1,708,564 $5,402,668 $5,179,578 
Operating income:
Segment operating income:
Electronic Instruments$352,437 $338,963 $1,050,915 $1,041,760 
Electromechanical163,875 131,519 436,481 345,312 
Total segment operating income516,312 470,482 1,487,396 1,387,072 
Corporate administrative expenses(27,932)(24,631)(82,561)(76,491)
Consolidated operating income$488,380 $445,851 $1,404,835 $1,310,581 

Page | 4
image_3.jpg


AMETEK, Inc.
Condensed Consolidated Balance Sheet
(In thousands)
September 30,December 31,
20252024
(Unaudited)
ASSETS
Current assets:
     Cash and cash equivalents$439,237 $373,999 
     Receivables, net1,135,967 948,830 
     Inventories, net1,153,074 1,021,713 
     Other current assets333,267 258,490 
          Total current assets3,061,545 2,603,032 
Property, plant and equipment, net845,603 818,611 
Right of use assets, net267,589 235,666 
Goodwill7,185,294 6,555,877 
Other intangibles, investments and other assets4,822,226 4,417,983 
          Total assets$16,182,257 $14,631,169 
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
     Short-term borrowings and current portion of long-term debt, net$1,038,143 $654,346 
     Accounts payable and accruals1,611,660 1,444,241 
          Total current liabilities2,649,803 2,098,587 
Long-term debt, net1,426,072 1,425,375 
Deferred income taxes and other long-term liabilities1,579,506 1,451,903 
Stockholders' equity10,526,876 9,655,304 
          Total liabilities and stockholders' equity$16,182,257 $14,631,169 
Page | 5
image_3.jpg


AMETEK, Inc.
Reconciliations of GAAP to Non-GAAP Financial Measures
(In thousands, except per share amounts)
(Unaudited)

Three Months Ended September 30,
20252024
EIG Segment operating income (GAAP)$352,437 $338,963 
Acquisition-related costs(1)
7,750 — 
Adjusted EIG Segment operating income (Non-GAAP)$360,187 $338,963 
Operating income (GAAP)$488,380 $445,851 
Acquisition-related costs(1)
7,750 — 
Adjusted Operating income (Non-GAAP)$496,130 $445,851 
Other Income (Expense), net$(17,901)$(1,888)
Acquisition-related costs(1)
11,992 — 
Adjusted Other Income (Expense), net$(5,909)$(1,888)
Diluted earnings per share (GAAP)$1.60 $1.47 
Acquisition-related costs(1)
0.09 — 
Income tax benefit on acquisition-related costs(1)
(0.02)— 
Pretax amortization of acquisition-related intangible assets0.29 0.26 
Income tax benefit on amortization of acquisition-related intangible assets(0.07)(0.06)
Rounding (0.01)
Adjusted Diluted earnings per share (Non-GAAP)$1.89 $1.66 
Change
EIG Segment operating margin (GAAP)28.3 %29.9 %
Acquisition-related costs(1)
0.6 %— %
Dilutive impact of acquisitions(2)
1.5 %— %
Adjusted EIG Segment operating margin (Non-GAAP)30.4 %29.9 %0.5 %
Operating income margin (GAAP)25.8 %26.1 %
Acquisition-related costs(1)
0.4 %— %
Dilutive impact of acquisitions(2)
0.8 %— %
Adjusted Operating income margin (Non-GAAP)27.0 %26.1 %0.9 %
______________________
(1) - Acquisition-related costs are comprised of integration costs recorded in Cost of Sales and transaction costs unique to completed business combinations recorded in Other Income (Expense), net.
(2) - Excludes the dilutive impact from acquisitions completed in the last twelve months.
Page | 6
image_3.jpg


AMETEK, Inc.
Reconciliations of GAAP to Non-GAAP Financial Measures
(Unaudited)


Forecasted Diluted Earnings Per Share
Three Months EndedYear Ended
December 31, 2025December 31, 2025
LowHighLowHigh
Diluted earnings per share (GAAP)$1.68 $1.73 $6.34 $6.39 
Pretax amortization of acquisition-related intangible assets0.29 0.29 1.20 1.20 
Income tax benefit on amortization of acquisition-related intangible assets(0.07)(0.07)(0.29)(0.29)
Acquisition-related costs(1)
  0.09 0.09 
Income tax benefit on acquisition-related costs(1)
  (0.02)(0.02)
Adjusted Diluted earnings per share (Non-GAAP)$1.90 $1.95 $7.32 $7.37 
______________________
(1) - Acquisition-related costs are comprised of integration costs recorded in Cost of Sales and transaction costs unique to completed business combinations recorded in Other Income (Expense), net.


Use of Non-GAAP Financial Information
The Company supplements its consolidated financial statements presented on a U.S. generally accepted accounting principles (“GAAP”) basis with certain non-GAAP financial information to provide investors with greater insight, increased transparency and allow for a more comprehensive understanding of the information used by management in its financial and operational decision-making. Reconciliation of non-GAAP measures to their most directly comparable GAAP measures are included in the accompanying financial tables. These non-GAAP financial measures should be considered in addition to, and not as a replacement for, or superior to, the comparable GAAP measure, and may not be comparable to similarly titled measures reported by other companies.
The non-GAAP financial measures referenced in this press release include adjusted operating income, adjusted operating margin, and adjusted earnings per share. These measures are adjusted to exclude items that management does not consider indicative of AMETEK’s ongoing operational performance, such as after-tax acquisition-related intangible amortization and acquisition-related costs (including transaction costs, purchase accounting adjustments, and integration costs).
In providing forward-looking guidance for quarterly and full-year GAAP and non-GAAP measures, the Company has not included adjustments, such as acquisition-related costs, whose timing and/or magnitude are contingent on future events.
The Company believes that these measures provide useful information to investors by reflecting additional ways of viewing AMETEK’s operations that, when reconciled to the comparable GAAP measure, helps our investors to better understand the long-term profitability trends of our business, and facilitates easier comparisons of our profitability to prior and future periods and to our peers.
Page | 7
image_3.jpg